<DOC>
	<DOCNO>NCT02870153</DOCNO>
	<brief_summary>The aim study compare activity safety Oxaliplatin S-1 ( SOX ) Oxaliplatin Capecitabine ( XELOX ) patient peritoneal metastasis colorectal cancer .</brief_summary>
	<brief_title>SOX Versus XELOX Patients With Peritoneal Metastasis Colorectal Cancer</brief_title>
	<detailed_description>Peritoneal dissemination colorectal cancer common , traditionally regard end-stage disease amenable palliation systemic chemotherapy ( sCT ) , supportive care .Oxaliplatin oral fluoropyrimidines ( capecitabine S-1 ) active agent colorectal cancer . Recent phase II trial combination chemotherapy oxaliplatin S-1 ( OS ) several phase II trial combination chemotherapy oxaliplatin capecitabine ( XELOX ) demonstrate good activity mild toxicity advanced colorectal cancer . Oxaliplatin S-1 capecitabine distinct mechanisms action overlap key toxicity . Furthermore , oxaliplatin fluorouracil show highly synergistic , preclinical model also subsequent clinical trial .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Histologically confirm colorectal adenocarcinoma , initially diagnose recurred Peritoneal metastasis colorectal cancer At least one unidimensional measurable lesion RECIST criterion Age 18 80 year old Estimated life expectancy ≥3 month ECOG performance status ≤2 Adequate bone marrow function ( WBCs ≥ 4,000/µL absolute neutrophil count ≥ 1,500/µL , platelet ≥ 100,000/µL ) Adequate kidney function ( creatinine &lt; 1.5 mg/dL ) Adequate liver function ( bilirubin &lt; 2.0 mg/dL , transaminase level &lt; 2.5 time upper normal limit ) Written inform consent Other tumor type adenocarcinoma Previous history chemotherapy ( exception : neoadjuvant adjuvant chemotherapy without oxaliplatin ) Presence CNS metastasis , psychosis , seizure Obvious bowel obstruction Evidence serious gastrointestinal bleeding Past concurrent history neoplasm colorectal adenocarcinoma , except curatively treat nonmelanoma skin cancer situ carcinoma cervix uteri Pregnant lactate woman , woman childbearing potential employ adequate contraception Other serious illness medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>